Mechanisms of Cellular Immune Dysfunction in Patients with Hepatitis C Virus and

丙型肝炎病毒和病毒感染患者细胞免疫功能障碍的机制

基本信息

  • 批准号:
    8397545
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-10-01 至 2014-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Hepatitis C virus (HCV) is a blood-borne, hepatotropic RNA virus with a high propensity for chronic infection that can progress to cirrhosis and liver cancer. HCV persistence is a significant health problem particularly among U.S. veterans with increased seroprevalence. Consistent with a role for T cells in the viral infections, HCV persists with a dysfunctional virus-specific effector T cell response while HCV-associated liver disease progression is accelerated in the setting of HIV-associated CD4 T cell dysfunction. Based on emerging literature and our own preliminary data, we hypothesize that HIV-associated immune dysregulation results in heightened HCV- specific effector T cell dysfunction through immune inhibitory signals either directly through the costimulatory receptors (e.g. PD-1, CTLA-4) or indirectly by the induction of immune regulatory T cells and cytokines. We also propose that targeted inhibition of these pathways can enhance virus-specific effector function. To this end, the following 3 specific aims will examine if: 1) Chronic evolution with the loss of HCV-specific T cell effector function correlates with increased inhibitory costimulatory receptor expression and regulatory T cell frequency in patients with acute hepatitis C with and without HIV coinfection; 2) Immune inhibitory pathways are accentuated in HIV/HCV coinfected patients compared to HCV monoinfected patients with clinical consequence; 3) HCV-specific effector T cell dysfunction in HIV/HCV-infected patients can be reversed by blocking negative costimulatory and regulatory pathways. The proposed studies will provide insights to underlying immunological mechanisms of T cell dysfunction in HCV-infected patients with HIV coinfection, with potential therapeutic implications. Potential Impact on Veterans Health Care HCV is highly prevalent among U.S. veterans, contributing to significant morbidity and mortality due to chronic hepatitis C, progressive liver cirrhosis and liver cancer development. HIV coinfection markedly increases the morbidity and mortality in HCV-infected patients. The proposed studies (using samples from both veteran and non-veteran subjects) will provide insights to underlying mechanisms of T cell dysfunction and the impact of HIV-associated immune dysfunction in HCV pathogenesis, relevant for immunotherapeutic development that can benefit HCV-infected veterans.
描述(由申请人提供): 丙型肝炎病毒(丙型肝炎病毒)是一种血液传播的嗜肝RNA病毒,具有高度的慢性感染倾向,可发展为肝硬化和肝癌。丙型肝炎持续存在是一个重大的健康问题,特别是在血清阳性率上升的美国退伍军人中。与T细胞在病毒感染中的作用一致,丙型肝炎病毒持续存在功能障碍的病毒特异性效应T细胞反应,而在HIV相关的CD4T细胞功能障碍的背景下,丙型肝炎病毒相关的肝病进展加速。根据新出现的文献和我们自己的初步数据,我们假设HIV相关的免疫失调通过免疫抑制信号直接通过共刺激受体(如PD-1、CTLA-4)或间接通过诱导免疫调节T细胞和细胞因子而导致丙型肝炎病毒特异性效应器T细胞功能障碍。我们还提出,靶向抑制这些途径可以增强病毒特异性效应器的功能。为此,以下3个特定目标将检验是否:1)慢性演变与丙型肝炎病毒特异性T细胞效应器功能丧失相关,与抑制性共刺激受体表达和调节性T细胞频率增加相关;2)与单一感染丙型肝炎病毒的患者相比,HIV/丙型肝炎病毒混合感染患者的免疫抑制通路明显增强;3)艾滋病毒/丙型肝炎病毒感染者的丙型肝炎病毒特异性效应器T细胞功能障碍可以通过阻断负的共刺激和调节通路来逆转。这项拟议的研究将为丙型肝炎病毒感染合并艾滋病毒感染患者T细胞功能障碍的潜在免疫学机制提供见解,具有潜在的治疗意义。对退伍军人医疗保健的潜在影响丙型肝炎病毒在美国退伍军人中非常普遍,导致慢性丙型肝炎、进行性肝硬变和肝癌的显著发病率和死亡率。HIV合并感染显著增加了丙型肝炎病毒感染者的发病率和死亡率。拟议的研究(使用退伍军人和非退伍军人受试者的样本)将为T细胞功能障碍的潜在机制以及艾滋病毒相关免疫功能障碍在丙型肝炎发病中的影响提供洞察力,这与免疫治疗开发相关,从而使丙型肝炎病毒感染的老兵受益。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kyong-Mi Chang其他文献

Kyong-Mi Chang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kyong-Mi Chang', 18)}}的其他基金

Genetics of Cardiometabolic Diseases in the VA Population
VA 人群心脏代谢疾病的遗传学
  • 批准号:
    10516086
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Genetics of Cardiometabolic Diseases in the VA Population
VA 人群心脏代谢疾病的遗传学
  • 批准号:
    10412924
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Genetics of Cardiometabolic Diseases in the VA Population
VA 人群心脏代谢疾病的遗传学
  • 批准号:
    10789045
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Genetics of Cardiometabolic Diseases in the VA Population
VA 人群心脏代谢疾病的遗传学
  • 批准号:
    9033652
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Genetics of Cardiometabolic Diseases in the VA Population
VA 人群心脏代谢疾病的遗传学
  • 批准号:
    10058760
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Mechanisms of Cellular Immune Dysfunction in Patients with Hepatitis C Virus and
丙型肝炎病毒和病毒感染患者细胞免疫功能障碍的机制
  • 批准号:
    7908872
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
Mechanisms of Cellular Immune Dysfunction in Patients with Hepatitis C Virus and
丙型肝炎病毒和病毒感染患者细胞免疫功能障碍的机制
  • 批准号:
    8195858
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
Mechanisms of Cellular Immune Dysfunction in Patients with Hepatitis C Virus and
丙型肝炎病毒和病毒感染患者细胞免疫功能障碍的机制
  • 批准号:
    7796265
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
Immune regulation and co-stimulation in treatment outcome of chronic hepatitis B
免疫调节与共刺激对慢性乙型肝炎治疗效果的影响
  • 批准号:
    8545811
  • 财政年份:
    2008
  • 资助金额:
    --
  • 项目类别:
Immune regulation and co-stimulation in treatment outcome of chronic hepatitis B
免疫调节与共刺激对慢性乙型肝炎治疗效果的影响
  • 批准号:
    7932950
  • 财政年份:
    2008
  • 资助金额:
    --
  • 项目类别:

相似海外基金

経胸壁心臓超音波のBlood Speckle Imagingを用いた大動脈弓部病変評価の研究
经胸心脏超声血斑成像评价主动脉弓病变的研究
  • 批准号:
    24K10591
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A cluster randomized controlled trial to evaluate pharmacy-based health promotion program to improve blood pressure control in Bangladesh, India and Pakistan
一项整群随机对照试验,旨在评估孟加拉国、印度和巴基斯坦基于药房的健康促进计划,以改善血压控制
  • 批准号:
    23K24566
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Open Access Block Award 2024 - NHS Blood and Transplant NHSBT School
2024 年开放获取块奖 - NHS 血液和移植 NHSBT 学校
  • 批准号:
    EP/Z532551/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
  • 批准号:
    MR/X032809/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
A methodology to connect functionalized gonadal constructs to a chick embryo through mechanically induced blood vessels from an egg
一种通过鸡蛋机械诱导血管将功能化性腺结构连接到鸡胚胎的方法
  • 批准号:
    24K15741
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
STTR Phase I: A Completely Non-Toxic Blood Bag That Keeps Blood Healthier, Longer
STTR 第一阶段:完全无毒的血袋,使血液保持更健康、更长久
  • 批准号:
    2335363
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
How blood vessel stiffness regulates their growth and maintenance
血管硬度如何调节其生长和维持
  • 批准号:
    DE240101055
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Discovery Early Career Researcher Award
Engaging the over 50s to ensure the sustainability of our blood supply
让 50 多岁的人参与进来,确保我们血液供应的可持续性
  • 批准号:
    LP220200819
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Linkage Projects
Applying a Program Science approach for strengthening partnerships and advancing embedded research to optimize public health programming for HIV and sexually transmitted and blood-borne infections among criminalized populations in the Global South
应用计划科学方法来加强伙伴关系并推进嵌入式研究,以优化南半球犯罪人群中针对艾滋病毒、性传播和血源性感染的公共卫生规划
  • 批准号:
    502554
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
Designing and fabricating artificial blood cells for global shortages
设计和制造人造血细胞应对全球短缺
  • 批准号:
    DE240100236
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Discovery Early Career Researcher Award
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了